Abstract
Aptamers selected from a large random sequence pool are oligonucleic acid or peptide molecules that bind to a specific target molecule with high affinity and sensitivity. Targets range from small molecules to proteins and peptides, even tissue or cells. As such, aptamers have captured the attention of scientists actively developing technologies for diverse biomedical applications. Particularly, when functionalized with nanomaterials, aptamers offer properties for both biomedical and bioanalytical applications. In this review, these features and properties are discussed with particular emphasis on the use of aptamer-based biosensor/detection platforms.
Keywords: Aptamer, biological analysis, cancer cells, nanomaterials, SELEX
Current Molecular Medicine
Title:Development of Aptamer-Based Nanomaterials for Biological Analysis
Volume: 13 Issue: 4
Author(s): Y. Pu, H. Liu, B. Liu, J. Liao, J. Liu, Z. Zhao and W. Tan
Affiliation:
Keywords: Aptamer, biological analysis, cancer cells, nanomaterials, SELEX
Abstract: Aptamers selected from a large random sequence pool are oligonucleic acid or peptide molecules that bind to a specific target molecule with high affinity and sensitivity. Targets range from small molecules to proteins and peptides, even tissue or cells. As such, aptamers have captured the attention of scientists actively developing technologies for diverse biomedical applications. Particularly, when functionalized with nanomaterials, aptamers offer properties for both biomedical and bioanalytical applications. In this review, these features and properties are discussed with particular emphasis on the use of aptamer-based biosensor/detection platforms.
Export Options
About this article
Cite this article as:
Pu Y., Liu H., Liu B., Liao J., Liu J., Zhao Z. and Tan W., Development of Aptamer-Based Nanomaterials for Biological Analysis, Current Molecular Medicine 2013; 13 (4) . https://dx.doi.org/10.2174/1566524011313040016
DOI https://dx.doi.org/10.2174/1566524011313040016 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy
Current Genomics Effect of Hsp90 Inhibitor KW-2478 on HepG2 Cells
Anti-Cancer Agents in Medicinal Chemistry Cancer Immunotherapy - Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Potential Chemopreventive Role of Boldine Against Hepatocellular Carcinoma via Modulation of Cell Cycle Proteins in Rat Model
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Antibodies
Current Molecular Medicine Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
Current Molecular Medicine Neuroprotective Gene Therapy for the Treatment of Inherited Retinal Degeneration
Current Gene Therapy Targeting Aldose Reductase for the Treatment of Cancer
Current Cancer Drug Targets MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential
Current Genomics Promotion of Apoptosis in Cancer Cells by Selective Purine-Derived Pharmacological CDK Inhibitors: One Outcome, Many Mechanisms
Current Pharmaceutical Design Recent Developments of DNA Poisons - Human DNA Topoisomerase IIα Inhibitors - as Anticancer Agents
Current Pharmaceutical Design Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Current Drug Metabolism Brain Tumor Causes, Symptoms, Diagnosis and Radiotherapy Treatment
Current Medical Imaging miRNAs in Gastrointestinal and Liver Cancers: Their Perspectives and Clinical Applications
Current Pharmaceutical Design Retrovirus Translation Initiation: Issues and Hypotheses Derived from Study of HIV-1
Current HIV Research Impact of Liver Cancer Somatic Mutations on Protein Structures and Functions
Current Proteomics Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy
Mini-Reviews in Medicinal Chemistry The Tumor Suppressor Gene ARF as a Sensor of Oxidative Stress
Current Molecular Medicine Pathophysiological and Clinical Aspects of Iron Chelation Therapy in MDS
Current Pharmaceutical Design Metallothioneins and Cancer
Current Protein & Peptide Science